| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |